Clinical Trial: A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

U.S., Oct. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07220616) titled 'A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies' on Oct. 21.

Brief Summary: This clinical trial is designed to assess the safety, preliminary efficacy, and pharmacokinetics (PK) of DS3790a monotherapy and combination regimens in participants with hematological malignancies.

Study Start Date: Nov. 15

Study Type: INTERVENTIONAL

Condition: Hematological Malignancies

Intervention: DRUG: DS3790a

Administered as specified in the protocol

DRUG: Combination drug

Administered as specified in the protocol

DRUG: Combination drug

Administered as specified in the protocol

Recruitment Status: NOT_YET_...